Cboe BZX · GLBL
Pacer MSCI World Industry Advantage ETF financials
$28.62−0.64%
Close Sep 28, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Quarter | Q4 '22 Dec 31 | Q3 '22 Sep 30 | Q2 '22 Jun 30 | Q1 '22 Mar 31 | Q4 '21 Dec 31 | Q3 '21 Sep 30 | Q2 '21 Jun 30 |
|---|---|---|---|---|---|---|---|
| Revenue | $19.4M | $18.6M | $18.9M | $20.0M | — | — | — |
| Gross profit | $19.4M | $18.6M | $18.9M | $20.0M | — | — | — |
| Gross margin | 100.0% | 100.0% | 100.0% | 100.0% | — | — | — |
| Operating income | -$3.2M | -$378.0K | $1.1M | $1.2M | -$474.6K | -$239.4K | -$211.3K |
| Net income | -$7.1M | -$674.0K | $965.0K | $899.0K | $359.9K | -$4.7M | $7.4M |
| Net margin | −36.4% | −3.6% | 5.1% | 4.5% | — | — | — |
| Diluted EPS | $-1002.27 | $-96.19 | $137.72 | $129.24 | $0.01 | $-0.14 | $0.21 |
| EBITDA | -$3.2M | $205.0K | $1.7M | $1.8M | -$474.6K | -$239.4K | -$211.3K |
| Operating cash flow | $3.3M | $1.9M | $4.9M | -$3.3M | -$164.5K | -$115.6K | -$59.5K |
| Free cash flow | $3.2M | $1.9M | $4.9M | -$3.3M | — | — | — |
| Diluted shares | 0.0M | 0.0M | 0.0M | 0.0M | 29.1M | 34.5M | 34.5M |
Balance sheet
| Period end | Dec 31 | Sep 30 | Jun 30 | Mar 31 | Dec 31 | Sep 30 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $7.1M | $464.0K | $565.2K | $109.2K | $551.3K | $715.8K |
| Short-term investments | $145.0K | — | — | — | — | — |
| Total debt | $21.2M | $477.0K | $463.3K | $0.00 | $0.00 | $0.00 |
| Total assets | $92.0M | $347.6M | $346.2M | $345.3M | $345.7M | $345.9M |
| Total liabilities | $74.1M | $19.4M | $26.2M | $25.1M | $35.4M | $36.1M |
| Shareholders' equity | $17.9M | -$18.9M | -$25.6M | -$24.9M | -$34.7M | -$35.2M |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology